Бета2-адренергичен агонист: Разлика помеѓу преработките
| [проверена преработка] | [проверена преработка] |
Избришана содржина Додадена содржина
Ред 24:
* [[формотерол]]
* [[салметрол]]
=== Ultra-long-acting β<sub>2</sub> agonists<ref>{{cite journal|last1=Cazzola|first1=Mario|last2=Matera|first2=Maria Gabriella|last3=Lötvall|first3=Jan|title=Ultra long-acting β<sub>2</sub>-agonists in development for asthma and chronic obstructive pulmonary disease|journal=Expert Opinion on Investigational Drugs|date=15 July 2005|volume=14|issue=7|pages=775–83|doi=10.1517/13543784.14.7.775|pmid=16022567}}<!--|accessdate=22 February 2016--></ref><ref>{{cite journal|last1=Cazzola|first1=Mario|last2=Calzetta|first2=Luigino|last3=Matera|first3=Maria Gabriella|title=β<sub>2</sub>-adrenoceptor agonists: current and future direction|journal=British Journal of Pharmacology|date=May 2011|volume=163|issue=1|pages=4–17|doi=10.1111/j.1476-5381.2011.01216.x|pmid=21232045|pmc=3085864}}</ref> ===
* [[абедитерол]]<ref>{{cite journal|last1=Beier|first1=J|last2=Fuhr|first2=R|last3=Massana|first3=E|last4=Jiménez|first4=E|last5=Seoane|first5=B|last6=de Miquel|first6=G|last7=Ruiz|first7=S|title=Abediterol (LAS100977), a novel long-acting β<sub>2</sub>-agonist: Efficacy, safety and tolerability in persistent asthma|journal=Respiratory Medicine|date=October 2014|volume=108|issue=10|pages=1424–1429|doi=10.1016/j.rmed.2014.08.005|pmid=25256258|url=http://www.resmedjournal.com/article/S0954-6111(14)00287-X/pdf|accessdate=25 March 2016}}</ref>
* [[кармотерол]]
* [[индакатерол]]—Arcapta Neohaler <small>([[United States|U.S.]])</small>, Onbrez Breezhaler <small>([[European Union|EU]], [[Russia|RU]])</small>
* [[олодатерол]]—Striverdi Respimat
* [[вилантерол]]
[[Категорија:Лекови]]
| |||